Anzeige
Meldung des Tages: Der 9,5 Mio. € Kupferfehler des Marktes – Und solche Fehler korrigieren sich schnell

Galapagos News

Aktie
WKN:  A0EAT9 ISIN:  BE0003818359 US-Symbol:  GLPGF Branche:  Biotechnologie Land:  Belgien
28,22 €
-0,68 €
-2,35%
06.03.26
Depot/Watchlist
Marktkapitalisierung *
1,83 Mrd. €
Streubesitz
42,53%
KGV
-21,92
Index-Zuordnung
-
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,43: MN4HF2
Werbung

Galapagos News

06.03.26 - GlobeNewswire
Galapagos Creates New Subscription Right Plan
Mechelen, Belgium; March 6, 2026, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,750,000 ...
05.03.26 - GlobeNewswire
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
Seasoned Life Sciences Executive Joins Galapagos with Strong Track Record in Change Management
04.03.26 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium ; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
23.02.26 - GlobeNewswire
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Strategic reset positions Galapagos for long-term value creation Robust 2025 year-end cash and financial investments of €3.0 billion and ongoing collaboration with Gilead enable ...
19.02.26 - GlobeNewswire
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  
Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board Mechelen, Belgium; February 19, 2026, 22:01 CET — Galapagos NV ...
16.02.26 - GlobeNewswire
Galapagos Receives Transparency Notification from Bank of America
Mechelen, Belgium ; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America.
10.02.26 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium ; February 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
05.01.26 - GlobeNewswire
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
Mechelen, Belgium ; January 5, 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-...
18.12.25 - GlobeNewswire
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of ...
08.12.25 - GlobeNewswire
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early ...
26.11.25 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium ; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
05.11.25 - GlobeNewswire
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update
Strategic review process concluded with intention to wind down cell therapy business, representing optimal capital allocation pathway to support a stronger and sustainable future ...
03.11.25 - GlobeNewswire
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma
30.10.25 - GlobeNewswire
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board Mechelen, Belgium; October 30, 2025, 21:01 CET — Galapagos ...
23.10.25 - GlobeNewswire
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors
Mechelen, Belgium ; October 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new in vitro pharmacological data from its ...
21.10.25 - GlobeNewswire
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos ...
16.10.25 - GlobeNewswire
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Mechelen, Belgium ; October 16, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Mr. Fred Blakeslee as Executive Vice President ...
01.10.25 - GlobeNewswire
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business  
Mechelen, Belgium ; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, ...
07.08.25 - GlobeNewswire
Galapagos Creates New Subscription Right Plan
Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its  Board of Directors created 1,800,000 s...
06.08.25 - GlobeNewswire
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the United States Food ...

Newssuche

Videos

newspaper
04.03.26 +13,80%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »